Total Payments
$50,892
2024 Payments
$710.15
Companies
54
Transactions
399
Medicare Patients
1,921
Medicare Billing
$379,697
Payment Breakdown by Category
Consulting$44,208 (86.9%)
Food & Beverage$6,084 (12.0%)
Education$348.09 (0.7%)
Travel$252.42 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $44,208 | 7 | 86.9% |
| Food and Beverage | $6,084 | 371 | 12.0% |
| Education | $348.09 | 20 | 0.7% |
| Travel and Lodging | $252.42 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $42,169 | 109 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,737 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $416.42 | 29 | $0 (2024) |
| Lilly USA, LLC | $414.99 | 29 | $0 (2020) |
| PFIZER INC. | $344.08 | 28 | $0 (2024) |
| Genentech USA, Inc. | $331.81 | 26 | $0 (2020) |
| Amgen Inc. | $322.58 | 18 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $305.00 | 9 | $0 (2020) |
| PUMA BIOTECHNOLOGY, INC. | $297.97 | 5 | $0 (2021) |
| Clovis Oncology, Inc. | $258.19 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $710.15 | 38 | Daiichi Sankyo Inc. ($221.50) |
| 2023 | $609.83 | 52 | Daiichi Sankyo Inc. ($369.91) |
| 2022 | $358.63 | 39 | Daiichi Sankyo Inc. ($233.60) |
| 2021 | $1,212 | 5 | Daiichi Sankyo Inc. ($1,028) |
| 2020 | $43,981 | 28 | Daiichi Sankyo Inc. ($40,161) |
| 2019 | $1,219 | 92 | Genentech USA, Inc. ($160.67) |
| 2018 | $2,235 | 115 | Clovis Oncology, Inc. ($237.20) |
| 2017 | $566.08 | 30 | Millennium Pharmaceuticals, Inc. ($91.10) |
All Payment Transactions
399 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.36 | General |
| Category: Hematology/Oncology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Oncology | ||||||
| 07/29/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Oncology | ||||||
| 07/23/2024 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/13/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/11/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.04 | General |
| 05/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Oncology | ||||||
| 05/14/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: ONCOLOGY | ||||||
| 05/07/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.06 | General |
| 05/02/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/01/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Oncology | ||||||
| 04/19/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 478 | 3,017 | $229,184 | $59,940 |
| 2022 | 20 | 546 | 1,836 | $312,061 | $98,258 |
| 2021 | 17 | 519 | 2,358 | $283,082 | $116,697 |
| 2020 | 15 | 378 | 16,334 | $269,933 | $104,801 |
Total Patients
1,921
Total Services
23,545
Medicare Billing
$379,697
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 112 | $19,600 | $7,371 | 37.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $16,500 | $5,412 | 32.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 12 | 170 | $11,900 | $2,156 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $5,600 | $1,784 | 31.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 31 | $5,425 | $1,726 | 31.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 11 | 62 | $6,200 | $1,482 | 23.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 16 | 22 | $4,180 | $1,139 | 27.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 14 | $3,500 | $1,118 | 31.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 16 | 16 | $4,000 | $1,048 | 26.2% |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | Office | 2022 | 11 | 78 | $2,340 | $917.28 | 39.2% |
| 71260 | Ct scan of chest with contrast | Office | 2022 | 12 | 15 | $6,015 | $820.18 | 13.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 46 | $2,760 | $518.09 | 18.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 23 | 46 | $2,300 | $477.86 | 20.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2022 | 11 | 490 | $25,480 | $391.53 | 1.5% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 12 | 60 | $18,000 | $356.79 | 2.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 14 | 27 | $864.00 | $205.47 | 23.8% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 65 | 279 | $44,570 | $44,570 | 100.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 255 | $70,125 | $25,353 | 36.2% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 25 | 92 | $37,904 | $10,535 | 27.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 146 | $25,550 | $10,212 | 40.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 36 | 70 | $24,500 | $9,846 | 40.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 26 | 26 | $13,000 | $4,389 | 33.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 65 | $11,375 | $3,645 | 32.0% |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | Office | 2021 | 11 | 33 | $6,666 | $1,875 | 28.1% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 19 | 122 | $8,540 | $1,652 | 19.3% |
About Dr. Deepna Jaiswal, D.O
Dr. Deepna Jaiswal, D.O is a Hematology & Oncology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2011. The National Provider Identifier (NPI) number assigned to this provider is 1447541594.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepna Jaiswal, D.O has received a total of $50,892 in payments from pharmaceutical and medical device companies, with $710.15 received in 2024. These payments were reported across 399 transactions from 54 companies. The most common payment nature is "Consulting Fee" ($44,208).
As a Medicare-enrolled provider, Jaiswal has provided services to 1,921 Medicare beneficiaries, totaling 23,545 services with total Medicare billing of $379,697. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Plano, TX
- Active Since 04/25/2011
- Last Updated 02/06/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1447541594
Products in Payments
- Enhertu (Drug) $41,392
- INJECTAFER (Drug) $619.95
- Rubraca (Drug) $258.19
- ZEJULA (Drug) $194.92
- XTANDI (Drug) $184.89
- VERZENIO (Drug) $182.18
- NINLARO (Drug) $172.84
- Nerlynx (Drug) $162.04
- VELCADE (Drug) $156.44
- NERLYNX (Drug) $135.93
- AFINITOR (Drug) $135.54
- LYNPARZA (Drug) $134.91
- ENHERTU (Drug) $127.82
- OPDIVO (Biological) $117.97
- Nplate (Biological) $117.46
- BOSULIF (Drug) $109.68
- KEYTRUDA (Biological) $107.66
- JEVTANA (Drug) $107.38
- Neulasta (Biological) $101.49
- IBRANCE (Drug) $90.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Plano
Ruben Saez, Md, MD
Hematology & Oncology — Payments: $117,913
Hematology & Oncology $117,913
Dr. Thuy Le, M.d, M.D
Hematology & Oncology — Payments: $22,323
Hematology & Oncology $22,323
Andrew Kovoor, Md, MD
Hematology & Oncology — Payments: $13,233
Hematology & Oncology $13,233
Virginia Kinsella, Md, MD
Hematology & Oncology — Payments: $13,129
Hematology & Oncology $13,129
Dr. Wendy Mahone-Johnson, Md, MD
Hematology & Oncology — Payments: $8,818
Hematology & Oncology $8,818
Dr. Nandita Rao, Md, MD
Hematology & Oncology — Payments: $4,337
Hematology & Oncology $4,337